Kang Liu
- Molecular Biology top 5%
- Immunology top 5%
- Cancer Research top 5%
- Oncology top 10%
- Epidemiology
- Co-authors
- Pramod K. SrivastavaYasuaki TamuraPing PengGang FengJonathan MansbridgeWeei-Chin LinGuiqin SongKent T. Symons
- Topics
- RNA modifications and cancer (7 papers)Cancer Cells and Metastasis (7 papers)Cancer, Hypoxia, and Metabolism (7 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Kang Liu
82 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Molecular Biology 1.3k
- Immunology 555
- Cancer Research 358
- Oncology 331
- Epidemiology 235
Countries citing papers authored by Kang Liu
This map shows the geographic impact of Kang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang Liu more than expected).
Fields of papers citing papers by Kang Liu
This network shows the impact of papers produced by Kang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang Liu. The network helps show where Kang Liu may publish in the future.
Co-authorship network of co-authors of Kang Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Kang Liu. A scholar is included among the top collaborators of Kang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kang Liu. Kang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 4 | |
| 11 | 46 | |
| 12 | 29 | |
| 13 | 21 | |
| 14 | 14 | |
| 15 | 16 | |
| 16 | 104 | |
| 17 | 14 | |
| 18 | Clinical efficiency of compound Kushen injection combined with radiotherapy in the treatment of patients with cervical cancer | 2 |
| 19 | 18 | |
| 20 | Tumor Necrosis Factor-α Expression in Ischemic Neurons | 53 |
About Kang Liu
Kang Liu is a scholar working on Cancer Research, Rheumatology and Molecular Biology, having authored 89 papers that have together received 2.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cancer Cells and Metastasis (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Immunology (555 citations), Cancer Research (358 citations) and Molecular Biology (1.3k citations). Kang Liu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Pramod K. Srivastava, Yasuaki Tamura, Ping Peng, Gang Feng, Jonathan Mansbridge, Weei-Chin Lin, Guiqin Song, Kent T. Symons, Emmett Pinney and Fang‐Tsyr Lin. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.